Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 34
18
Diseases
63
Unique genes
0.095
Avg. similarity score
Congenital myasthenic syndrome
Most-connected disease (14 links)
Disease
Searched: Myasthenic syndrome
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Myasthenic syndrome
Congenital myasthenic syndrome
Postsynaptic congenital myasthenic syndrome
Presynaptic congenital myasthenic syndrome
Fetal akinesia deformation sequence
congenital myasthenic syndrome 7
congenital myasthenic syndrome 8
congenital myasthenic syndrome 10
congenital myasthenic syndrome 6
congenital myasthenic syndrome 9
neuronopathy, distal hereditary motor, type 7A
ALG2-congenital disorder of glycosylation
Ataxia, spastic, autosomal dominant
Intellectual developmental disorder seizures behavioral
congenital myasthenic syndrome 12
myasthenic syndrome, congenital, 1b, fast-channel
Alstrom syndrome
Thyroid gland neoplasms
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Congenital myasthenic syndrome | 14 | 14 | 29 |
| Myasthenic syndrome | 12 | 12 | 40 |
| Postsynaptic congenital myasthenic syndrome | 8 | 8 | 12 |
| Presynaptic congenital myasthenic syndrome | 8 | 8 | 11 |
| Fetal akinesia deformation sequence | 6 | 6 | 12 |
| congenital myasthenic syndrome 7 | 4 | 4 | 1 |
| congenital myasthenic syndrome 8 | 4 | 4 | 1 |
| congenital myasthenic syndrome 10 | 3 | 3 | 1 |
| congenital myasthenic syndrome 6 | 3 | 3 | 1 |
| congenital myasthenic syndrome 9 | 3 | 3 | 1 |
| neuronopathy, distal hereditary motor, type 7A | 3 | 3 | 1 |
| ALG2-congenital disorder of glycosylation | 2 | 2 | 1 |
| Ataxia, spastic, autosomal dominant | 2 | 2 | 2 |
| Intellectual developmental disorder seizures behavioral | 2 | 2 | 1 |
| congenital myasthenic syndrome 12 | 2 | 2 | 1 |
| myasthenic syndrome, congenital, 1b, fast-channel | 2 | 2 | 1 |
| Alstrom syndrome | 1 | 1 | 1 |
| Thyroid gland neoplasms | 1 | 1 | 13 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| AGRN | 5 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 8, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome and 1 more |
| DOK7 | 5 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 10, Fetal akinesia deformation sequence, Myasthenic syndrome and 1 more |
| MUSK | 5 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 9, Fetal akinesia deformation sequence, Myasthenic syndrome and 1 more |
| SYT2 | 5 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 7, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome and 1 more |
| CHAT | 4 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 6, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| CHRNA1 | 4 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, myasthenic syndrome, congenital, 1b, fast-channel, Postsynaptic congenital myasthenic syndrome |
| COL13A1 | 4 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| RAPSN | 4 / 18 | Congenital myasthenic syndrome, Fetal akinesia deformation sequence, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| SLC18A3 | 4 / 18 | Congenital myasthenic syndrome, Fetal akinesia deformation sequence, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| SLC5A7 | 4 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, neuronopathy, distal hereditary motor, type 7A, Presynaptic congenital myasthenic syndrome |
| ALG14 | 3 / 18 | Congenital myasthenic syndrome, Intellectual developmental disorder seizures behavioral, Myasthenic syndrome |
| ALG2 | 3 / 18 | ALG2-congenital disorder of glycosylation, Congenital myasthenic syndrome, Myasthenic syndrome |
| CHRNB1 | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| CHRND | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| CHRNE | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| GFPT1 | 3 / 18 | Congenital myasthenic syndrome, congenital myasthenic syndrome 12, Myasthenic syndrome |
| LRP4 | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| MYO9A | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| SCN4A | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Postsynaptic congenital myasthenic syndrome |
| SLC25A1 | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| SNAP25 | 3 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| VAMP1 | 3 / 18 | Ataxia, spastic, autosomal dominant, Myasthenic syndrome, Presynaptic congenital myasthenic syndrome |
| ALMS1 | 2 / 18 | Alstrom syndrome, Fetal akinesia deformation sequence |
| CHD8 | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| COLQ | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| DPAGT1 | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| GMPPB | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| PLEC | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| PREPL | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| RPH3A | 2 / 18 | Congenital myasthenic syndrome, Myasthenic syndrome |
| TAPBPL | 2 / 18 | Ataxia, spastic, autosomal dominant, Myasthenic syndrome |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Acetylcholine Neurotransmitter Release Cycle | Reactome | 4 / 17 | 44.9× | 1.55e-6 | 7.65e-5 ✓ sig. |
| Highly sodium permeable postsynaptic acetylcholine nicotinic receptors | Reactome | 3 / 7 | 81.7× | 4.74e-6 | 1.94e-4 ✓ sig. |
| Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein | Reactome | 3 / 11 | 52.0× | 2.20e-5 | 6.82e-4 ✓ sig. |
| N-Glycan biosynthesis | KEGG | 3 / 55 | 10.4× | 2.97e-3 | 3.14e-2 ✓ sig. |
| Defective DPAGT1 causes DPAGT1-CDG (CDG-1j) and CMSTA2 | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Defective GFPT1 causes CMSTA1 | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Imatinib-resistant PDGFR mutants | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Sunitinib-resistant PDGFR mutants | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Regorafenib-resistant PDGFR mutants | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Sorafenib-resistant PDGFR mutants | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| PDGFR mutants bind TKIs | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Defective SLC5A7 causes distal hereditary motor neuronopathy 7A (HMN7A) | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Defective SLC22A5 causes systemic primary carnitine deficiency (CDSP) | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Defective ALG2 causes ALG2-CDG (CDG-1i) | Reactome | 1 / 1 | 191× | 5.25e-3 | 4.67e-2 ✓ sig. |
| Laminin interactions | Reactome | 2 / 28 | 13.6× | 9.38e-3 | 6.82e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| synaptic transmission, cholinergic | GO:0007271 | 7 / 25 | 83.1× | 1.61e-12 | 7.15e-10 ✓ sig. |
| neuromuscular junction development | GO:0007528 | 6 / 35 | 50.8× | 1.73e-9 | 3.67e-7 ✓ sig. |
| skeletal muscle acetylcholine-gated channel clustering | GO:0071340 | 4 / 9 | 132× | 1.46e-8 | 2.37e-6 ✓ sig. |
| acetylcholine receptor signaling pathway | GO:0095500 | 5 / 28 | 53.0× | 3.43e-8 | 4.93e-6 ✓ sig. |
| membrane depolarization | GO:0051899 | 5 / 32 | 46.3× | 6.95e-8 | 9.01e-6 ✓ sig. |
| skeletal muscle contraction | GO:0003009 | 5 / 32 | 46.3× | 6.95e-8 | 9.01e-6 ✓ sig. |
| muscle contraction | GO:0006936 | 6 / 85 | 20.9× | 4.09e-7 | 4.04e-5 ✓ sig. |
| regulation of postsynaptic membrane potential | GO:0060078 | 5 / 59 | 25.1× | 1.61e-6 | 1.25e-4 ✓ sig. |
| neuromuscular synaptic transmission | GO:0007274 | 4 / 31 | 38.3× | 3.45e-6 | 2.30e-4 ✓ sig. |
| excitatory postsynaptic potential | GO:0060079 | 5 / 69 | 21.5× | 3.53e-6 | 2.34e-4 ✓ sig. |
| regulation of synaptic assembly at neuromuscular junction | GO:0008582 | 3 / 10 | 89.0× | 4.31e-6 | 2.74e-4 ✓ sig. |
| chemical synaptic transmission | GO:0007268 | 7 / 236 | 8.8× | 1.42e-5 | 7.13e-4 ✓ sig. |
| acetylcholine biosynthetic process | GO:0008292 | 2 / 3 | 198× | 3.35e-5 | 1.37e-3 ✓ sig. |
| dolichol-linked oligosaccharide biosynthetic process | GO:0006488 | 3 / 19 | 46.8× | 3.40e-5 | 1.39e-3 ✓ sig. |
| protein N-linked glycosylation | GO:0006487 | 4 / 62 | 19.1× | 5.65e-5 | 2.04e-3 ✓ sig. |